Janssen Biotech, Inc.

Ann Lacombe

Qiang Chen

Jinquan Luo

Ellen Chi

Wilson Edwards

Debra Gardner

Yevgeniya Orlovsky

Karen Duffy

Damon Hamel

Ravi Malaviya

Deepti Wilkinson

Shannon Hitchcock

Yanxia Guo

Pejman Soroosh

Melissa Swiecki

Suzanne Cole

Matt Husovsky

H Mimi Zhou

Christian Martinez

Paul H Kim

Zemeda Ainekulu

Quynh Nguyen

In certain aspects, the disclosure relates to anti-idiotype antibodies and antigen-binding portions thereof that specifically bind a KL2B413 containing protein, e.g., an antibody or antigen-binding portions thereof. In some aspects, the anti-idiotype antibodies and antigen-binding portions of the present disclosure can be used in methods to detect and quantify cells expressing chimeric antigen receptors that include KL2B413.

Anti-idiotypic antibodies against anti-KLK2 antibodies

In certain aspects, the disclosure relates to anti-idiotype antibodies and antigen-binding portions thereof that specifically bind a GP5B83 containing protein, e.g., an antibody or antigen-binding portions thereof. In some aspects, the anti-idiotype antibodies and antigen-binding portions of the present disclosure can be used in methods to detect and quantify cells expressing chimeric antigen receptors that include GP5B83.

Anti-idiotypic antibodies against anti-GPRC5D antibodies

Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.

Antibodies that specifically bind PD-1 and methods of use

Growing community of inventors

San Diego, CA, United States of America

Ann Lacombe